Publications Database

Latest additions:
2025-12-01
10:30
OpenAccess [DZNE-2025-01307] Journal Article
; ;
Supplementing Single‐Arm Trials with External Control Arms—Evaluation of German Real‐World Data
As single-arm trials (SATs) are increasingly used in pharmaceutical research, the validity of such study designs needs to be critically assessed. We characterize the feasibility of supplementing SATs with real-world data (RWD)-derived external control arms by determining the proportion of SATs on breast cancer and amyotrophic lateral sclerosis (ALS) for which an external control arm based on RWD can be constructed. [...]

Detailed record - Similar records
2025-12-01
10:27
[DZNE-2025-01306] Journal Article
; ; ; et al
Proof of concept: Portable ultra-low-field MRI for the assessment of brain tumors
BackgroundHigh-field (HF) MRI is a standard diagnostic tool for brain cancer, but its high cost and technical demands limit accessibility in low- and middle-income countries. Recent advancements in ultra-low field (ULF) MRI technology, including the development of portable scanners, offer a promising solution to these challenges. [...]

Detailed record - Similar records
2025-12-01
10:24
OpenAccess [DZNE-2025-01305] Journal Article
; ; ; et al
Deprescribing drugs with anticholinergic effects in older patients with increased risk of dementia in the multicomponent intervention study AgeWell.de
AimDrugs with anticholinergic effects are often considered as potentially inappropriate medications, especially for older patients, and deprescribing such drugs may improve cognitive function. The aim was to investigate the effectiveness of counselling on drug risks as part of a multimodal intervention to prevent cognitive decline.MethodsThe AgeWell.de study, a multi-centre, cluster-randomized controlled study, was conducted in 123 German general practices between June 2018 and January 2022. [...]
OpenAccess: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2025-12-01
10:21
OpenAccess [DZNE-2025-01304] Journal Article
;
Toward targeted dementia prevention: Population attributable fractions and risk profiles in Germany
INTRODUCTIONEffective dementia prevention requires understanding the distribution of modifiable risk factors and identifying high-risk subgroups. We estimated the prevention potential in Germany and identified risk profiles to inform precision public health.METHODSWe analyzed nationally representative data from the 2023 German Aging Survey (n = 4992). [...]

Detailed record - Similar records
2025-12-01
10:17
[DZNE-2025-01303] Journal Article
; ; ; et al
On the Impact of Artifacts Induced by Mismatches Between Auto‐Calibration Signal and Accelerated 3D GRE Data at 11.7T
PurposeThe study aims at investigating field inhomogeneity artifacts arising from remote locations in the FOV and encountered in accelerated 3D gradient-recalled echo (GRE) sequences at ultra-high field, and at providing mitigation strategies.MethodsMeasurements were conducted at 11.7T using a head-shaped phantom and an accelerated 3D GRE sequence with either integrated or external auto-calibration signal (ACS) lines. Simulations were performed to reproduce the artifacts. [...]

Detailed record - Similar records
2025-12-01
10:12
OpenAccess [DZNE-2025-01302] Journal Article
; ; ; et al
Serum p‐tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder
Annals of neurology AOP, ana.78109 () [10.1002/ana.78109]
ObjectiveAssess the performance of serum phosphorylated tau 217 (p-tau217) and neurofilament light chain (NfL) in predicting risk of cognitive impairment or phenoconversion to dementia in individuals with iRBD.MethodsWe measured serum p-tau217 and NfL levels by electrochemiluminescence across 4 polysomnographically confirmed iRBD cohorts (n = 300), including individuals who phenoconverted to Parkinson's disease (PD) (n = 51), dementia with Lewy bodies (DLB) (n = 22), and multiple system atrophy (MSA) (n = 5).ResultsSerum p-tau217 levels were increased in individuals with iRBD and cognitive impairment (CI) on testing defined as Montreal Cognitive Assessment <26 or subthreshold parkinsonism. p-Tau217 differentiated individuals with iRBD who developed PD with CI (PD-CI) or DLB from PD phenoconverters with normal cognition (area under curve [AUC] = 0.82; 95% confidence interval, 0.70–0.93) and from iRBD non-phenoconverters with normal cognition (AUC = 0.83; 95% confidence interval, 0.77–0.89) [...]

Detailed record - Similar records
2025-12-01
10:08
OpenAccess [DZNE-2025-01301] Journal Article
; ; ; et al
Digital Outcomes of Upper Limb Ataxia Capture Meaningful Longitudinal Change and Treatment Response
Movement disorders 40(11), 2486 - 2496 () [10.1002/mds.70012]
BackgroundDigital-motor outcomes promise better responsiveness than clinician-reported outcomes in ataxia trials. However, their patient meaningfulness and sensitivity to change remain to be demonstrated, particularly in the upper limb domain.ObjectivesValidation of quantitative motor (Q-Motor) assessment for upper limb ataxia against patient-reported outcomes and regarding sensitivity to both longitudinal and treatment-induced change, the latter in n-of-1 treatment settings.MethodsSingle-center longitudinal assessment of finger tapping, diadochokinesia, grip-lift, spiral drawing, and target reaching in (1) 36 cross-genotype ataxia patients and 20 controls, validating digital measures for correlations with patient-reported outcome measure (PROM)-ataxia, 2-weeks test–retest reliability, and sensitivity to change within a trial-relevant 1-year follow-up, anchored in Patient Global Impression of Change (PGI-C); and (2) two patients with spinocerebellar ataxia type 27B (SCA27B) on versus off treatment with 4-aminopyridine.ResultsTwenty-four digital measures correlated with the PROM-ataxia upper-limb composite (|ρ| = 0.4–0.7) and had excellent test–retest reliability (ICC = 0.91–0.99). [...]

Detailed record - Similar records
2025-12-01
10:05

Detailed record - Similar records
2025-12-01
10:00
OpenAccess [DZNE-2025-01299] Journal Article
; ; ; et al
Dermal Alpha‐Synuclein Aggregation in Seed Amplification Assays for Parkinson's Disease Subtype Differentiation
BackgroundSkin biopsies and seed amplification assays (SAA) provide a sensitive and potentially quantitative method to detect alpha-synuclein (a-syn) aggregation in peripheral nerve fibers in Parkinson's disease (PD). Relating to the previously published hypothesis that PD may either originate in the peripheral (body-first) or central (brain-first) nervous system, we investigated whether patients with clinical features that have been reported to be associated with a suspected body-first subtype of PD exhibit higher levels of a-syn aggregation in dermal nerve fibers compared to those without these features. [...]
OpenAccess: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2025-11-11
18:10
OpenAccess [DZNE-2025-01253] Journal Article
; ; ; et al
Heterogeneous plasticity of amygdala interneurons in associative learning and extinction
Neural circuits undergo experience-dependent plasticity to form long-lasting memories, but how inhibitory interneurons contribute to this process remains poorly understood. Using miniature microscope calcium imaging, we monitored the activity of large amygdala interneuron populations in freely moving mice during fear learning and extinction. [...]
OpenAccess: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records